Sanofi, Regeneron expand testing of potential coronavirus treatment
Share:
(Reuters) - Sanofi and Regeneron Pharmaceuticals Inc have expanded a clinical trial of their rheumatoid arthritis drug Kevzara as a coronavirus treatment to patients outside the United States.The companies said enrolments for the mid-to-late stage trial of Kevzara, an immune-system modifying drug known as a monoclonal antibody, have now started in Italy, Spain, Germany, France, Canada, and Russia. The U.S. trials began last week.The trial, expected to enroll about 300 patients, will recruit..